GlaxoSmithKline to change training-payment practices

Drugmaker GlaxoSmithKline P.L.C. has announced changes in the way it pays for physician-training sessions and other practices that industry critics have derided as too cozy with the medical community. Starting next year, the company will pay only academic, medical, and professional institutions to organize continuing medical-education sessions for physicians. Glaxo is immediately ending its practice of paying event producers or other commercial providers to organize sessions.